Therapeutics by cytotoxic metabolite accumulation: Pemetrexed causes ZMP accumulation, AMPK activation, and mTOR inhibition

Por Racanelli, Alexandra C., Rothbart, Scott B., Heyer, Cortney L., Moran, Richard G.
Publicado em 2009